Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
Human FGF19 Protein expressed in Escherichia coli (E. coli) - ABIN935365
Borello, Cobos, Long, McWhirter, Murre, Rubenstein: FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. in Neural development 2008
Human FGF19 Protein expressed in Wheat germ - ABIN1354010
Uchiyama, Naito, Takagi, Mizushima, Hayashi, Handa, Ishikawa, Yagi, Kokura, Yoshikawa: FGF19 protects colonic epithelial cells against hydrogen peroxide. in Digestion 2011
Human FGF19 Protein expressed in Escherichia coli (E. coli) - ABIN413241
Becker-Pauly, Barré, Schilling, Auf dem Keller, Ohler, Broder, Schütte, Kappelhoff, Stöcker, Overall: Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates. in Molecular & cellular proteomics : MCP 2011
FGF19 gene amplification corresponds with an increased dependency upon FGF19/FGFR4 autocrine signaling in HNSCC.
These data demonstrate receptor- and species-specific differential activity of FGF15 and FGF19 which should be taken into consideration when FGF19 is used as a substitute for FGF15.
FGF19 may be a valuable diagnostic marker for the identification of patients with colorectal adenomas.
Independent of glucose tolerance status, serum FGF19 levels were inversely associated with visceral fat accumulation.
FGF19 expressions are decreased in the placenta and rectus muscle of women with gestational diabetes mellitus. This might contribute to the pathophysiology or development of gestational diabetes mellitus.
FGF19 is induced by hypoxia/reoxygenation (H/R) - treatment in cardiomyocytes. FGF19 knockdown augments H/R-induced injury. FGF19 overexpression protects cardiomyocytes from H/R-induced injury.
Study shows that FXR is phosphorylated at Y67 by non-receptor tyrosine kinase, Src, in response to postprandial FGF19 which is critical for its nuclear localization and transcriptional regulation of bile acids levels and identifies Src-mediated FXR phosphorylation as a potential therapeutic target and biomarker for bile acids-related enterohepatic diseases.
In children and adolescents with NAFLD, hepatic FXR protein content and plasma FGF19 concentrations were decreased compared.
Study showed that FGF19 amplification is a genetic event in Chinese lung squamous cell carcinoma (LSCC) patients, with a frequency of 37.5%. FGF19 amplified LSCC cells express relatively higher levels of FGF19 mRNA expression, and downregulation of FGF19 expression can induce significant cell killing effects in vitro and in vivo.
FGFR4/FGF19 autocrine signaling mediates the survival of a subset of basal-like breast cancer cells
FGF19 copy number may increase in hepatocellular carcinoma accompanying a complete response to sorafenib treatment
Study demonstrates that elevated FGF19 expression or hyperactivation of FGF19/FGFR4 signaling in hepatocellular carcinoma cells is one of the main mechanisms of sorafenib resistance.
This is the first study to elucidate FGF19/FGFR4 signaling in favor of hepatocellular carcinoma cells developing from fatty liver
High expression of FGF19 is associated with hepatocellular carcinoma.
Findings show that FGF19 provides a cytoprotective role against ER stress by activating a FGFR4-GSK3beta-Nrf2 signaling cascade, suggesting targeting this signaling node as a candidate therapeutic regimen for hepatocellular carcinoma (HCC) management.
Fibroblast growth factor 19 levels in human portal blood are higher than in arterial blood. Fibroblast growth factor 19 is released by the portal-drained viscera under fasted steady state conditions.
Intestinal sensing of highly elevated levels of conjugated bile acids in blood promotes FGF15/FGF19 signaling, reducing hepatic bile acid synthesis and modulating bile acid transporters.
serum FGF19 and FGF21 and hepatic Klotho expression are inversely associated with hepatic damage in children with NAFLD
Administering FGF19, or suitable mimetic, as a pharmacological intervention to increase circulating levels of FGF19 and suppress BA synthesis by inhibiting CYP7A1 gene expression is likely to provide therapeutic benefits for many PBC patients
Amplification of FGF19 was validated in independent LSCC samples. Furthermore, FGF19 stimulated LSCC cell growth in vitro. These data implicate FGF19 as a potential driver gene in LSCC with clinic characteristics as smoking.
Fgf19 signaling is critical for embryonic forebrain development through its interaction with hedgehog.
This study reveals an important role for FOXC1 in the direct regulation of the FGF19-FGFR4-MAPK pathway to promote both the development and maintenance of anterior segment structures within the eye.
Fgf19 is required for zebrafish lens and retina development.
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes including embryonic development cell growth, morphogenesis, tissue repair, tumor growth and invasion. This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development.
, fibroblast growth factor 19
, fibroblast growth factor 15